Treatment of Retinal Vasculitis in Antiphospholipid Syndrome

Retinal vasculitis occurring in the setting of occlusive vasculitis — particularly antiphospholipid syndrome — represents a distinct clinical situation. The occlusive phenotype shapes the direction of treatment.

This protocol addresses occlusive retinal vasculitis, as seen in conditions such as antiphospholipid syndrome. Identifying the underlying occlusive mechanism is the key step before selecting therapy.

Management targets the thrombotic mechanism and involves systemic antithrombotic therapy — the full regimen, including agent selection, sequencing, and monitoring, is detailed in the complete protocol.